Microchimerism in the rheumatoid nodules of patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 64, Issue 2, 2012, Pages 380-388

  Chan, William F N ^a   Atkins, Christopher J ^b   Naysmith, David ^c   Van Der Westhuizen, Nicholas ^c   Woo, Janet ^c   Nelson, J Lee ^d  

^a Fred Hutchinson Cancer Research Center   (United States)

^b VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; Y CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; CHIMERISM; FEMALE; GENOTYPE; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; RHEUMATOID NODULE;

EID: 84856384399     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33358     Document Type: Article

References (43)

1. Gammill HS, Nelson JL,. Naturally acquired microchimerism. Int J Dev Biol 2010; 54: 531-43.
2. Bowes J, Barton A,. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008; 47: 399-402.
3. Guthrie KA, Dugowson CE, Voigt LF, Koepsell TD, Nelson JL,. Does pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis Rheum 2010; 62: 1842-8.
4. Nelson JL,. Naturally acquired microchimerism: for better or for worse [editorial]. Arthritis Rheum 2009; 60: 5-7.
5. Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009; 60: 73-80.
6. Yan Z, Aydelotte T, Gadi VK, Guthrie KA, Nelson JL,. Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism. Arthritis Rheum 2011; 63: 640-4.
7. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA,. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93: 705-8. (Pubitemid 26041153)
8. Garcia-Patos V,. Rheumatoid nodule. Semin Cutan Med Surg 2007; 26: 100-7. (Pubitemid 46829961)
9. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
10. Ziff M,. The rheumatoid nodule. Arthritis Rheum 1990; 33: 761-7. (Pubitemid 20205754)
11. Hromadnikova I, Zlacka D, Hien Nguyen TT, Sedlackova L, Zejskova L, Sosna A,. Fetal cells of mesenchymal origin in cultures derived from synovial tissue and skin of patients with rheumatoid arthritis. Joint Bone Spine 2008; 75: 563-6.
12. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004; 50: 906-14. (Pubitemid 38326192)
13. Lambert NC, Lo YM, Erickson TD, Tylee TS, Guthrie KA, Furst DE, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100: 2845-51.
14. Yan Z, Lambert NC, Guthrie KA, Porter AJ, Loubiere LS, Madeleine MM, et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005; 118: 899-906. (Pubitemid 41097469)
15. Holoshitz J,. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010; 22: 293-8.
16. Gregersen PK, Silver J, Winchester RJ,. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13. (Pubitemid 18005792)
17. Du Montcel ST, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S, et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005; 52: 1063-8. (Pubitemid 40530112)
18. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, et al. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001; 184: 703-6. (Pubitemid 32234987)
19. Lambert NC, Pang JM, Yan Z, Erickson TD, Stevens AM, Furst DE, et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005; 64: 845-8. (Pubitemid 40733906)
20. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP,. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93: 3127-39. (Pubitemid 29200808)
21. Sato T, Fujimori K, Sato A, Ohto H,. Microchimerism after induced or spontaneous abortion. Obstet Gynecol 2008; 112: 593-7.
22. Stevens AM, Hermes HM, Lambert NC, Nelson JL, Meroni PL, Cimaz R,. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 2005; 44: 187-91. (Pubitemid 40277401)
23. Fugazzola L, Cirello V, Beck-Peccoz P,. Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol 2011; 7: 89-97.
24. Matzinger P,. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045. (Pubitemid 24140436)
25. Athanasou NA, Quinn J, Woods CG, McGee JO,. Immunohistology of rheumatoid nodules and rheumatoid synovium. Ann Rheum Dis 1988; 47: 398-403.
26. Hedfors E, Klareskog L, Lindblad S, Forsum U, Lindahl G,. Phenotypic characterization of cells within subcutaneous rheumatoid nodules. Arthritis Rheum 1983; 26: 1333-9. (Pubitemid 14231478)
27. Highton J, Kean A, Hessian PA, Thomson J, Rietveld J, Hart DN,. Cells expressing dendritic cell markers are present in the rheumatoid nodule. J Rheumatol 2000; 27: 339-46. (Pubitemid 30095461)
28. Highton J, Palmer DG, Smith M, Hessian PA,. Phenotypic markers of lymphocyte and mononuclear phagocyte activation within rheumatoid nodules. J Rheumatol 1990; 17: 1130-6. (Pubitemid 20334687)
29. Mellbye OJ, Forre O, Mollnes TE, Kvarnes L,. Immunopathology of subcutaneous rheumatoid nodules. Ann Rheum Dis 1991; 50: 909-12.
30. Miyasaka N, Sato K, Yamamoto K, Goto M, Nishioka K,. Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis 1989; 48: 220-6. (Pubitemid 19071999)
31. Palmer DG, Hogg N, Highton J, Hessian PA, Denholm I,. Macrophage migration and maturation within rheumatoid nodules. Arthritis Rheum 1987; 30: 729-36. (Pubitemid 17145209)
32. Hessian PA, Highton J, Kean A, Sun CK, Chin M,. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum 2003; 48: 334-8. (Pubitemid 36278000)
33. Wikaningrum R, Highton J, Parker A, Coleman M, Hessian PA, Roberts-Thompson PJ, et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient. Arthritis Rheum 1998; 41: 1783-97. (Pubitemid 28465532)
34. Highton J, Hessian PA, Stamp L,. The rheumatoid nodule: peripheral or central to rheumatoid arthritis? Rheumatology (Oxford) 2007; 46: 1385-7. (Pubitemid 47317082)
35. Stamp LK, Easson A, Lehnigk U, Highton J, Hessian PA,. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arthritis Rheum 2008; 58: 1601-8. (Pubitemid 351847513)
36. De Almeida DE, Ling S, Pi X, Hartmann-Scruggs AM, Pumpens P, Holoshitz J,. Immune dysregulation by the rheumatoid arthritis shared epitope. J Immunol 2010; 185: 1927-34.
37. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
38. Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 2010; 62: 2876-85.
39. Weyand CM, Xie C, Goronzy JJ,. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89: 2033-9.
40. Toussirot E, Tiberghien P, Balblanc JC, Kremer P, Despaux J, Dupond JL, et al. HLA DRB1* alleles in rheumatoid nodulosis: a comparative study with rheumatoid arthritis with and without nodules. Rheumatol Int 1998; 17: 233-6. (Pubitemid 28192759)
41. Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA,. Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 Caucasian patients with rheumatoid arthritis. Arthritis Rheum 2004; 50: 753-62. (Pubitemid 38331966)
42. James EA, Moustakas AK, Bui J, Papadopoulos GK, Bondinas G, Buckner JH, et al. HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets. Arthritis Rheum 2010; 62: 2909-18.
43. Wegner N, Lundberg K, Kinloch A, Fisher B, Malmstrom V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233: 34-54.